This is the supplier profile page of Amoy Diagnostics Co., Ltd., where buyers can explore products, connect directly with the supplier for pricing inquiries.

China FlagChina

1.1

Xinyang, Xiamen

Add Favorite

|

Report Supplier

|
This business has not been verified yet.
If you are the business owner, verify now to manage this profile and connect with verified buyers. Verify Now

Business Description

Amoy Diagnostics provides state-of-the-art molecular diagnostic products and services to healthcare providers, academic institutions, and pharmaceutical companies. The company has a rich portfolio of tests that focuses on detecting mutations and measuring gene expression in FFPE cancer tissue. The assays are designed and tested in an ISO-13485 certified laboratory and assembled in a dedicated GMP-compliant manufacturing plant.  In addition to the EGFR, KRAS and BRAF tests, the company has kits for detecting mutations in JAK2, KIT, BCR-ABL, PIK3CA, EML4-ALK, P53 and the RET oncogene. Quantitative gene expression assays for excision repair (ERCC1), thymidine phosphorylase (TYMP), stathmin (STMN1), ribonucleotide reductase (RRM1) and other genes provide valuable information to help predict chemotherapy responses.   The assays are easy to perform, provide results in 90 minutes, and have been validated on several PCR  instruments that are commonly used in diagnostic laboratories. AmoyDx supplies EGFR tests to AstraZeneca in China.  ROS1 tests for pivotal clinical trial of Pfizer´s crizotinib in China, Korea, and Japan.   Located in beautiful Xiamen, China, Amoy Diagnostics is a privately held, well-financed company with a rich and growing pipeline of molecular diagnostic products. Our mission is to be a leading global supplier of high quality diagnostic products. We will accomplish this mission by: 1. Adhering to the strictest manufacturing standards to provide quality products at competitive prices. 2. Maintaining an unsurpassed level of customer service and satisfaction. 3. Pursuing scientific innovation as we provide our customers with practical  leading-edge technologies     and value-added products. 4. Creating a world-class organization that contributes positively to the lives of our employees, our customers, and the scientific community.   The EGFR, KRAS, BRAF, PIK3CA  EML4-ALK and ROS1 tests are approved for clinical use in China and are CE marked for IVD use in Europe.  assays are CE marked for IVD use in Europe. Any other use of the assays is for research purposes only. Â

Business Overview

Avg Response Time

≤ 1h

Amoy Diagnostics Co., Ltd. is a typical Chinese supplier focused on medical test kits, with a clear product offering in VTM Test Kits. Founded in 2008, the company has been active for nearly 15 years, which suggests stability and experience in the market. However, none of the key verification fields — documents, work email, account email, or phone — are confirmed, which raises red flags for buyer trust and due diligence. In international trade, verified contact and documentation are essential to confirm legitimacy and reduce fraud risk. Without these, buyers may hesitate to place large orders or share sensitive requirements. While the company is based in China, a country with strong manufacturing capacity, the lack of verification makes it harder to assess reliability. Buyers should request additional proof, such as a business license or a sample test, before moving forward.

Trade Capabilities

Business Terms

Preferred Payment Term:

Not specified

Preferred Trade Term:

Not specified

Port Of Loading:

Not specified

Accepted Currency:

USD

Trade Ability

Annual Revenue Amount:

Not specified

Numbers Of Employees:

Not specified

Avg Response Time:

-

Products / Services Offered

Register Banner